Tests:Hepatitis C Serology: Difference between revisions
Tests:Hepatitis C Serology
No edit summary |
Updated method Alinity |
||
| (7 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE: Hepatitis C Serology}} | {{DISPLAYTITLE: Hepatitis C Serology}} | ||
{{DEFAULTSORT: Hepatitis C Serology}} | |||
[[Category:Tests]] | [[Category:Tests]] | ||
[[Category:Biochemistry]] | [[Category:Biochemistry]] | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Overview == | ||
|- | |- | ||
|Department | |Department | ||
| Line 14: | Line 15: | ||
|Synonyms | |Synonyms | ||
|Anti HCV serology | |Anti HCV serology | ||
|- | |||
|Availability | |||
|Monday, Wednesday, and Friday afternoons | |||
Urgent testing available by arrangement | |||
|- | |- | ||
|Turnaround Time | |Turnaround Time | ||
|1 – | |1 – 4 days | ||
|- | |- | ||
|Stability – Add test | |Stability – Add test | ||
| Line 22: | Line 27: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Specimen Requirements == | ||
|- | |- | ||
|Specimen | |Specimen | ||
|Serum | |Serum or LiHep Plasma | ||
|- | |- | ||
|Preferred | |Preferred | ||
| | |<span style="background: #fbec5d"> Yellow-Top</span> serum separator tube | ||
|- | |- | ||
|Acceptable | |Acceptable | ||
| | |Plain <span style="background:#e30022"> Red-Top</span> or Li-Heparin <span style="background:#3cb371"> Green-Top </span> tube | ||
|- | |||
|Unacceptable | |||
|EDTA plasma | |||
|- | |- | ||
| | |Specimen Transportation | ||
|2 mL | | | ||
|- | |||
|Paediatric Requirements | |||
|2 mL plain adult <span style="background:#e30022"> Red-Top</span> or <span style="background:#3cb371"> Green-Top </span> | |||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Aliquot Requirements == | ||
|- | |- | ||
|Sample | |Sample | ||
| | |Serum or LiHep Plasma | ||
|- | |||
|Preferred Volume | |||
|1 mL | |||
|- | |- | ||
|Minimum Volume | |Minimum Volume | ||
| Line 52: | Line 63: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Clinical Information == | ||
|- | |- | ||
|Reference Intervals | |Reference Intervals | ||
| Line 58: | Line 69: | ||
|- | |- | ||
|Test Method | |Test Method | ||
| | |Abbott Alinity i series analyser using Abbott reagents. Chemiluminescent microparticle immunoassay. | ||
|- | |- | ||
|Advanced Notice | |Advanced Notice | ||
| Line 67: | Line 78: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Comments == | ||
|- | |- | ||
| colspan="2" |Where needlestick or similar injury involved, refer to | | colspan="2" |Where needlestick or similar injury involved, refer to protocol in Infection Control Manual, “Blood Borne Pathogen Response – Needle Stick Injury Protocol.” | ||
|} | |} | ||
{{DocMeta | |||
| owner = Crossley1 | |||
| review_ping = | |||
}} | |||